For the Inventor, By the Inventor

Enter assignee name

Tortola, Virgin Islands, British

Biohaven Therapeutics Ltd.

Calculating rank

USPTO Granted Patents = 33

EPO Patents = 5

Trademarks = 17

Forward Citations = 47

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Allen B Reitz (12 out of 101 patents)

Jay Edward Wrobel (11 out of 96 patents)

Garry Robert Smith (11 out of 33 patents)

4. Haiyan Bian (10 out of 35 patents)

5. Vladimir Coric (9 out of 17 patents)

6. Jeffery Claude Pelletier (8 out of 11 patents)

7. Robert Berman (8 out of 8 patents)

8. Lynn Resnick (4 out of 14 patents)

9. George T Topalov (4 out of 31 patents)

10. Justin K Belardi (4 out of 12 patents)

11. Charles A Flentge (4 out of 14 patents)

12. David A Mareska (4 out of 25 patents)

13. James S Hale (4 out of 14 patents)

14. Scott S Harried (4 out of 30 patents)

15. Michael E Bozik (3 out of 26 patents)

Core Competencies:

Riluzole Prodrugs

KV7 Channel Activators

Immunotherapy

Graves Disease

Alzheimer's Disease

Cancer Treatment

Topical Formulations

Combination Therapy

Galactose-Deficient Immunoglobulins

Furoimidazopyridine

Sublingual Formulation

CD16A Binding Agents

33 patents: Sort by Forward Citations

1. 12766133 - Compositions and methods for treating obsessive-compulsive disorder (2026-10-20),

2. 12685782 - BIFUNCTIONAL DEGRADERS FOR THE TREATMENT OF GRAVES DISEASE (2026-07-21),

3. 12673111 - BIFUNCTIONAL DEGRADERS OF GALACTOSE-DEFICIENT IMMUNOGLOBULINS (2026-07-07),

4. 12564579 - Topical formulations of (1S)-1-phenyl-2-pyridin-2-ylethanamine (2026-03-03),

5. 12491246 - Combination therapy of arms and natural killer cells (2025-12-09),

6. 12472165 - Riluzole prodrugs and their use (2025-11-18),

7. 12383619 - Use of glutamate modulating agents with immunotherapies to treat cancer (2025-08-12),

8. 12370176 - Methods of use for KV7 channel activators (2025-07-29),

9. 12364687 - Use of riluzole oral disintegrating tablets for treating diseases (2025-07-22),

10. 12351559 - Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators (2025-07-08),

11. 12343347 - Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis (2025-07-01),

12. 12297206 - Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of salt (2025-05-13),

13. 12295942 - Riluzole prodrugs and their use (2025-05-13),

14. 12286408 - KV7 channel activators compositions and methods of use (2025-04-29),

15. 12213965 - Riluzole prodrugs and their use (2025-02-04),

Company Overview

Biohaven Therapeutics Ltd. is a biopharmaceutical company focused on developing innovative therapies for neurological and psychiatric disorders. The organization specializes in the research and commercialization of novel treatments aimed at addressing unmet medical needs in these areas. With a commitment to advancing science and improving patient outcomes, Biohaven leverages its expertise in drug development and clinical research to bring new solutions to market. The company operates with a global perspective, aiming to make a significant impact in the healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

33 Patents

#20 in Tortola

#23 in Virgin Islands, British

#20,190 in the World

Tortola, Virgin Islands, British

Biohaven Therapeutics Ltd.

Forward Citations = 47

54 inventors:

Allen B Reitz (12 out of 101 patents)

Jay Edward Wrobel (11 out of 96 patents)

Garry Robert Smith (11 out of 33 patents)

4. Haiyan Bian (10 out of 35 patents)

5. Vladimir Coric (9 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biohaven Therapeutics Ltd.. Retrieved from https://idiyas.com/company/biohaven-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…